A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation Status
- Status
- UNKNOWN
- Phase
- N/A
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC
- Status
- UNKNOWN
- Phase
- NA
A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia
- Status
- COMPLETED
- Phase
- PHASE2
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN
- Status
- COMPLETED
- Phase
- N/A
Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Mono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients
- Status
- TERMINATED
- Phase
- PHASE2
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
- Status
- UNKNOWN
- Phase
- NA
NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation
- Status
- COMPLETED
- Phase
- PHASE2
Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
- Status
- UNKNOWN
- Phase
- PHASE2
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
- Status
- WITHDRAWN
- Phase
- PHASE3
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
- Status
- TERMINATED
- Phase
- PHASE3
Iressa as Second Line Therapy in Advanced NSCLC-Asia
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2